FDA Approves First-of-Its-Kind Device to Treat Pancreatic Cancer

12 Feb 20264 min read0 views

GIST

The U.S. Food and Drug Administration has approved a first-of-its-kind device for the treatment of adult patients with locally advanced pancreatic cancer.

Clinical Editorial

Summary

FDA News Releases published a clinical update in Research Highlights on 12 Feb 2026. The item focuses on FDA Approves First-of-Its-Kind Device to Treat Pancreatic Cancer. Open the detail page to review the full original feed content.